Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis.
Mont
Michael A
MA
Ulrich
Slif D
SD
Seyler
Thorsten M
TM
D053241:Apoprotein(a) / Q000235:genetics / Q000502:physiology*; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D010020:Osteonecrosis / Q000209:etiology* / Q000503:physiopathology; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications* / Q000235:genetics
D053241:Apoprotein(a)